Cardiovascular disease-focused Cleerly scored $192 million in Series C financing, a little more than a year after the company launched with a $43 million Series B.
The latest round, led by T. Rowe Price and Fidelity Management and Research Company, brings Cleerly's total raise to $248 million.
Other participants in the round include Sands Capital, Piper Sandler’s Merchant Banking and Heartland...
